BCM
Bayesian Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,269
| Closed | -$253K | – | 840 |
|
|
2024
Q3 | $253K | Buy |
+2,269
| New | +$253K | 0.03% | 516 |
|
|
2023
Q4 | – | Sell |
-4,858
| Closed | -$629K | – | 886 |
|
|
2023
Q3 | $629K | Buy |
4,858
+3,000
| +161% | +$388K | 0.07% | 320 |
|
|
2023
Q2 | $230K | Sell |
1,858
-8,029
| -81% | -$995K | 0.02% | 604 |
|
|
2023
Q1 | $1.45M | Buy |
9,887
+699
| +8% | +$102K | 0.18% | 167 |
|
|
2022
Q4 | $1.46M | Buy |
9,188
+3,600
| +64% | +$574K | 0.21% | 105 |
|
|
2022
Q3 | $745K | Buy |
+5,588
| New | +$745K | 0.15% | 186 |
|
|
2021
Q4 | – | Sell |
-4,889
| Closed | -$637K | – | 452 |
|
|
2021
Q3 | $637K | Sell |
4,889
-3,311
| -40% | -$431K | 0.18% | 149 |
|
|
2021
Q2 | $1.46M | Sell |
8,200
-1,111
| -12% | -$197K | 0.38% | 72 |
|
|
2021
Q1 | $1.53M | Buy |
+9,311
| New | +$1.53M | 0.35% | 71 |
|
|
2019
Q3 | – | Sell |
-16,007
| Closed | -$2.28M | – | 599 |
|
|
2019
Q2 | $2.28M | Buy |
+16,007
| New | +$2.28M | 0.47% | 53 |
|
|
2018
Q3 | – | Sell |
-1,300
| Closed | -$224K | – | 712 |
|
|
2018
Q2 | $224K | Buy |
+1,300
| New | +$224K | 0.05% | 491 |
|
|
2018
Q1 | – | Sell |
-1,862
| Closed | -$251K | – | 708 |
|
|
2017
Q4 | $251K | Buy |
+1,862
| New | +$251K | 0.05% | 454 |
|
|
2017
Q1 | – | Sell |
-7,600
| Closed | -$829K | – | 553 |
|
|
2016
Q4 | $829K | Buy |
+7,600
| New | +$829K | 0.21% | 181 |
|
|
2016
Q3 | – | Sell |
-1,700
| Closed | -$240K | – | 430 |
|
|
2016
Q2 | $240K | Buy |
+1,700
| New | +$240K | 0.14% | 275 |
|